Скачать или смотреть Revolutionizing Regulatory Submissions with GAI and SCA

Reimagining Regulatory Submissions: The Untapped Potential of Generative AI and Structured Content Authoring

In the realm of pharmaceutical development, time is of the essence, but so is rigorous compliance. At Enkrisi, we're pioneering a transformative approach to regulatory submissions. Leveraging the power of Generative Artificial Intelligence and advanced Structured Content Authoring, we're excited to announce that the creation of an Investigational New Drug (IND) application can now be achieved in a fraction of the traditional timeframe.

But we don't stop at INDs. Our innovative methods lay down a robust foundation for the ultimate submission goal: a fully compliant New Drug Application (NDA) or Biologics License Application (BLA). This isn't just about speed; it's about building a submission that's comprehensive, precise, and designed to navigate the stringent pathways of regulatory approval with unprecedented efficiency.

Enkrisi is at the forefront, integrating augmented intelligence with our deep expertise in drug regulations to redefine what's possible in drug development and compliance. Stay tuned for more updates on how we're changing the game.